Germline SMARCB1 mutations strongly predispose to rhabdoid tumors [31] and subsequent somatic loss of the other allele can lead to cancer formation. SMARCB1 biallelic loss is now used in diagnosing these tumors by detecting loss of protein expression in the nucleus by immunostaining [32]. The gene discussed is SMARCB1; the disease is rhabdoid tumor.